Table 5.
Clinical studies on emulgel dosage form.
| Identifier No | Active Constituent | Titile of the Study | Conditions | Referance |
|---|---|---|---|---|
| NCT05536193 | Metformin and salicylic acid | Topical Metformin Emulgel VS Salicylic Acid Peeling in Treatment of Acne Vulgaris | Acne Vulgaris | [77] |
| NCT03074162 | Diclofenac sodium & Capsaicin | Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy Volunteers | Inflammatory | [78] |
| NCT04579991 | Visnadin, ethyl ximeninate, coleus barbatus | Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women | Female Sexual FunctionVulvovaginal AtrophyPostmenopausal Atrophic Vaginitis | [79] |
| NCT04110860 | Voriconazole | Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel | Tinea Versicolor | [80] |
| NCT04110834 | Itraconazole | Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel | Tinea Versicolor | [81] |
| NCT03492541 | Propylene glycol-based eye drops | Evaluation of the Clinical Efficacy and Tolerability of SYSTANE Complete in Adult Patients With Dry Eye Disease Following Topical Ocular Use for 4 Weeks: A Multicenter Trial | Dry eye disease | [82] |
| NCT05641246 | Carbamide diclofenac |
Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine: A Randomized Controlled Trial. | Hand and Foot Syndrome | [83] |